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Abstract
Adenoid cystic carcinoma (ACC) is a rare malignant cancer that arises from secretory glands. Slow growth, perineural invasion, and late recur-
rences are the main characteristics of ACC. Only few cases of kidney metastases from ACC have been reported in the literature. We report here 
the case of a 66-year-old female patient who presented with bilateral renal metastases from ACC of the nasal cavity, detected 14 years after 
treatment of primary tumor and 6 years after metastasectomy of lung metastases. Histological examination confirmed diagnosis and the patient 
was treated with systemic chemotherapy. Radiological evaluation showed stability of the disease. However, a progression with occurrence of 
metastases in other sites (lung and bones) has been observed after 7 months. She is still receiving second-line chemotherapy. To the best of our 
knowledge, this is the second case of kidney metastases from ACC of the nasal cavity.
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Adenoid cystic carcinoma (ACC) is an uncommon neo-
plasm accounting for approximately 1% of all head and neck 
cancers (1). It is characterized by indolent clinical course 
and a high incidence of late metastases. We describe herein 
an uncommon case of renal metastases from ACC of the 
nasal cavity. This case improved our knowledge about this 
extremely rare site of metastases from ACC and emphasized 
the importance of a long-term follow up to detect any late 
metastases.
Case Report
In 2005, a 66-year-old female consulted for nasal obstruction 
and rhinorrhea evolving since 8 months. Clinical examina-
tion documented a left polypoid nasal lesion; tumor biopsy 
revealed an ACC. The patient underwent surgery followed 
by radiation therapy (64Gy). During follow-up, after 8 years, 
the patient presented a distant recurrence of the disease with 
solitaire lung metastases. No local relapse was observed. 
Metastasectomy of the lesion was practiced with economic 
margins, followed by radiotherapy (60Gy). In April 2019, the 
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patient presented at the hospital for a pain in the right flank. 
No other symptoms were reported. Computed tomography 
(CT) of the abdomen showed multiple hypodense nodular 
lesions of the two kidneys, the larger one measuring 30 × 
25 × 40 mm in the right kidney (Figure 1).
The patient was referred fora CT-guided renal biopsy. 
 Histology showed a cribriform growth pattern with two 
types of cells, monomorphic epithelial cells with a basophilic 
cytoplasm and myoepithelial cells, which was consistent with 
kidney metastases from ACC (Figure 2).
The patient was treated with chemotherapy: CAP (Cyclo-
phosphamide-Adriamycin-Cisplatinum) regimen (cyclophos-
phamide 500 mg/m2, adriamycin 50 mg/m2, and cis-platinum 
50 mg/m2). The radiological evaluation by a CT scan after 
six cycles of chemotherapy showed a stable disease. Within 
7 months, a progression of the disease was observed with the 
occurrence of lung and bone metastases. Therefore, second- 
line chemotherapy was indicated: capecitabine with bisphos-
phonates. Actually, the patient is still alive. After four cycles 
of capecitabine, a further line of chemotherapy has been 
started because of a progression of bone metastases. She is 
still receiving chemotherapy based on paclitaxel with disease 
stability.
Discussion
ACC is a rare malignancy, accounting for 1% of all head 
and neck tumors and 10% of malignant salivary glandneo-
plasm  (1). Most frequently, ACC involves minor salivary 
glands. The involvement of the nasal cavity is less common. 
ACC is characterized by low growth, perineural invasion, 
and a high frequency of late local recurrences and hema-
togenous metastases (2). The lung is the most common site 
of metastases, followed by bones, liver, and occasionally the 
brain (3). Renal metastases of ACC are extremely rare, and 
only few cases have been reported in the literature. Among 
these reported cases, metastases to the kidney originated 
from different sites such as breast, lung, auditory canal, and 
lacrymal gland. However, to our knowledge, this is the sec-
ond case describing renal metastasis from the nasal cavity. 
In our case, the patient experienced two relapses: at first in 
the lung after 8 years of treatment of the primary tumor and 
then in the kidney after a period of 6 years. This confirms 
the high tendency of ACC to metastasize. Renal metastases 
are usually asymptomatic and due to their location in the 
vascular plexus cortex, hematuria is rarely observed (4). In 
the current case, urinary symptoms have not been reported 
but a pain in the right flank was observed. Several CT fea-
tures of renal metastases have been reported such as solid, 
cystic masses or hemorrhagiclesions. Pet/CT findings may be 
helpful in the detection of those lesions and to differentiate 
between benign and malignant lesions. Qiu et al. reported a 
case of a singular metastatic ACC of the right kidney 3 years 
after the treatment of an ACC of submandibular gland. 
PET-CT revealed a moderate FDG intake by the renal lesion, 
and diagnosis was confirmed by histological examination 
after a right radical nephrectomy (4). Histological diagnosis 
of renal metastases remains necessary to avoid misdiagnos-
ing primary renal tumors. Management of kidney metastases 
of ACC is not well defined. Up to now, surgery is the main 
treatment method proposed (5). However, this approach 
wasn’t possible in our case because of the multiplicity of the 
lesions. Other treatment modalities, such as thermoablation, 
renal embolization, may be proposed in some patients, espe-
cially with painful lesions (6). Systemic chemotherapy with 
agents, such as cyclophosphamide, cis-platinum, 5 fluouracil, 
Figure 1: CT scan showing bilateral renal lesions.
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Figure2: (A) H&E photomicrographs showing renal localization of adenoid cystic carcinoma (*) with various growth patterns: 
Cribriform and trabecular, a characteristic cribriform pattern of adenoid cystic carcinoma (hematoxylin-eosin, ×100). (B) Crib-
riform growth pattern displaying several prominent pseudocysts surrounded by basaloid cells (hematoxylin-eosin, ×200); Arrows 
indicate renal tubules.
and doxorubin, may have some efficacy against metastatic 
ACC and must be considered when locoregional treatment 
is not indicated. Our patient presented a stabilization of the 
disease with CAP regimen; however, a progression with the 
occurrence of metastases in other sites was observed.
Conclusion
The particularity of this case relies on the rarity of renal 
metastasis from ACC, specifically of nasal cavity, and the 
complexity of its diagnosis and management. Likewise, cli-
nicians must be aware of the existence of this condition anda 
careful monitoring is recommended to detect any additional 
metastases from ACC.
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